Foresite Capital’s $900M VC fund bets on AI to aid biotech plays

June 12, 2024
Foresite Capital’s $900M VC fund bets on AI to aid biotech plays

Interesting article on PitchBook about Klein Hersh partners Foresite Capital and Vik Bajaj, who launched their AI drug discovery startup Xaira Therapeutics that Klein Hersh is helping to build out, with $1 billion funding. We’re inspired by the work they’re doing to redefine what’s possible in medicine, and passionate about partnering with other organizations innovating with AI across biotech, pharmaceutical, digital health, and the broader healthcare industry.